Retroviral vectors for gene therapy
Since their first clinical trial 20 years ago, retroviral (gretroviral and lentiviral) vectors have now been used in more than 350 gene-therapy studies. Retroviral vectors are particularly suited for gene-correction of cells due to long-term and stable expression of the transferred transgene(s), and...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 Nov 2010
|
| In: |
Future microbiology
Year: 2010, Jahrgang: 5, Heft: 10, Pages: 1507-1523 |
| ISSN: | 1746-0921 |
| DOI: | 10.2217/fmb.10.100 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2217/fmb.10.100 Verlag, lizenzpflichtig, Volltext: https://www.futuremedicine.com/doi/10.2217/fmb.10.100 
|
| Verfasserangaben: | Patrick Maier, Christof von Kalle, Stephanie Laufs |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1844069915 | ||
| 003 | DE-627 | ||
| 005 | 20230710141533.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230502s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fmb.10.100 |2 doi | |
| 035 | |a (DE-627)1844069915 | ||
| 035 | |a (DE-599)KXP1844069915 | ||
| 035 | |a (OCoLC)1389806274 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Maier, Patrick |d 1969- |e VerfasserIn |0 (DE-588)1022131273 |0 (DE-627)71692613X |0 (DE-576)360534732 |4 aut | |
| 245 | 1 | 0 | |a Retroviral vectors for gene therapy |c Patrick Maier, Christof von Kalle, Stephanie Laufs |
| 264 | 1 | |c 12 Nov 2010 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.05.2023 | ||
| 520 | |a Since their first clinical trial 20 years ago, retroviral (gretroviral and lentiviral) vectors have now been used in more than 350 gene-therapy studies. Retroviral vectors are particularly suited for gene-correction of cells due to long-term and stable expression of the transferred transgene(s), and also because little effort is required for their cloning and production. Several monogenic inherited diseases, mostly immunodeficiencies, can now be successfully treated. The occurrence of insertional mutagenesis in some studies allowed extensive analysis of integration profiles of retroviral vectors, as well as the design of lentiviral vectors with increased safety properties. These new-generation vectors will enable us to continue the successful story of gene therapy, and treat more patients and even more complex diseases. | ||
| 650 | 4 | |a gene therapy | |
| 650 | 4 | |a improved vector design | |
| 650 | 4 | |a insertional mutagenesis | |
| 650 | 4 | |a lentiviral vectors | |
| 650 | 4 | |a retroviral vectors | |
| 700 | 1 | |a Kalle, Christof von |d 1962- |e VerfasserIn |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
| 700 | 1 | |a Maier-Laufs, Stephanie |e VerfasserIn |0 (DE-588)1065011806 |0 (DE-627)815411588 |0 (DE-576)365910732 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future microbiology |d London : Taylor & Francis, 2006 |g 5(2010), 10, Seite 1507-1523 |h Online-Ressource |w (DE-627)518961389 |w (DE-600)2254620-0 |w (DE-576)398100543 |x 1746-0921 |7 nnas |a Retroviral vectors for gene therapy |
| 773 | 1 | 8 | |g volume:5 |g year:2010 |g number:10 |g pages:1507-1523 |g extent:7 |a Retroviral vectors for gene therapy |
| 856 | 4 | 0 | |u https://doi.org/10.2217/fmb.10.100 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.futuremedicine.com/doi/10.2217/fmb.10.100 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230502 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1065011806 |a Maier-Laufs, Stephanie |m 1065011806:Maier-Laufs, Stephanie |d 50000 |e 50000PM1065011806 |k 0/50000/ |p 3 |y j | ||
| 998 | |g 1036481115 |a Kalle, Christof von |m 1036481115:Kalle, Christof von |d 910000 |e 910000PK1036481115 |k 0/910000/ |p 2 | ||
| 998 | |g 1022131273 |a Maier, Patrick |m 1022131273:Maier, Patrick |d 60000 |e 60000PM1022131273 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1844069915 |e 4317240203 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 02.05.2023"],"relHost":[{"origin":[{"publisherPlace":"London ; London","dateIssuedKey":"2006","dateIssuedDisp":"2006-","publisher":"Taylor & Francis ; Future Medicine Ltd"}],"title":[{"title_sort":"Future microbiology","title":"Future microbiology"}],"part":{"issue":"10","extent":"7","text":"5(2010), 10, Seite 1507-1523","volume":"5","pages":"1507-1523","year":"2010"},"id":{"eki":["518961389"],"issn":["1746-0921"],"zdb":["2254620-0"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 28.05.2024"],"recId":"518961389","disp":"Retroviral vectors for gene therapyFuture microbiology","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2006 -"]}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1844069915"],"doi":["10.2217/fmb.10.100"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Retroviral vectors for gene therapy","title_sort":"Retroviral vectors for gene therapy"}],"language":["eng"],"person":[{"family":"Maier","display":"Maier, Patrick","given":"Patrick","role":"aut"},{"family":"Kalle","display":"Kalle, Christof von","given":"Christof von","role":"aut"},{"role":"aut","family":"Maier-Laufs","given":"Stephanie","display":"Maier-Laufs, Stephanie"}],"name":{"displayForm":["Patrick Maier, Christof von Kalle, Stephanie Laufs"]},"origin":[{"dateIssuedDisp":"12 Nov 2010","dateIssuedKey":"2010"}],"recId":"1844069915"} | ||
| SRT | |a MAIERPATRIRETROVIRAL1220 | ||